← Open Payments lookup

GORDON ZEIS: Open Payments

NPI 1568935864 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,078 in 160 payments from 14 companies in 2025. Trend: 2023 $1,318 · 2024 $2,146 · 2025 $4,078

Food & beverage: $3,855Education: $223
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$736
Alkermes, Inc.20$559
Janssen Pharmaceuticals, Inc16$558
Otsuka America Pharmaceutical, Inc.20$517
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$382
ABBVIE INC.21$341
Lundbeck LLC10$232
Braeburn Inc.5$202
E.R. Squibb & Sons, L.L.C.7$174
Vanda Pharmaceuticals Inc.7$141

Products named: REXULTI, INVEGA SUSTENNA, CAPLYTA, VRAYLAR, LYBALVI, UZEDY, AUSTEDO XR, ARISTADA.

Industry payments across PA — which companies pay providers there.